Intraperitoneal Instillation of Ropivacaine for Postoperative Pain Relief in Laparoscopic Sleeve Gastrectomy

Phase 2

Completed

• Conditions: Morbid obesity after sleeve gastrectomypain control with intraperitoneal infiltration of local anaesthetic; Visual Analog score; Postoperative Pain; Respiratory Effort; Incentive Spirometry

• Registration Number: TCTR20220717002
• Lead Sponsor: one

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2021-05-31
• Study Start: 2022-07-17
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 110

Inclusion Criteria

Inclusion
Obese Patients who are undergoing laparoscopic sleeve gastrectomy

Exclusion Criteria

Exclusion
1.Pre-existing chronic pain under pain clinic follow up
2.Allergy to ropivacaine
3.Preexisting Chronic Liver disease with Child-Pugh B or C
4.Preexisting Chronic kidney disease
5.Previous history of abdominal surgery

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Postoperative pain control at OT recovery area then 2, 6, 12, and 24 h after surgery. Visual Analogue Scale (VAS) Score

Secondary Outcome Measures

Name	Time	Method
Postoperative Respiratory Effort at 2, 6, 12, and 24h after surgery Incentive Spirometry Effort